Bafna Pharmaceuticals is engaged in the Business of manufacture of pharmaceutical products.
Financial Results:
Bafna Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹41.95 Crores up from ₹16.93 Crore year on year, a rise of 147.78%.
Total Expenses for Q1FY24 of ₹37.47 Crores up from ₹16.87 Crores year on year, a rise of 122.11%.
Consolidated Net Profit of ₹6.35 Crores up 366.91% from ₹1.36 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.68, up 370.18% from ₹0.57 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.